BE898819A - Dispositif osmotique - Google Patents

Dispositif osmotique

Info

Publication number
BE898819A
BE898819A BE0/212326A BE212326A BE898819A BE 898819 A BE898819 A BE 898819A BE 0/212326 A BE0/212326 A BE 0/212326A BE 212326 A BE212326 A BE 212326A BE 898819 A BE898819 A BE 898819A
Authority
BE
Belgium
Prior art keywords
osmotic
composition
osmotic device
compartment
surrounds
Prior art date
Application number
BE0/212326A
Other languages
English (en)
Inventor
P S L Wong
B Barclay
J C Deters
F Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE898819(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of BE898819A publication Critical patent/BE898819A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Abstract

On prévoit un dispositif osmotique comprenant une paroi formée au moins en partie d'une matière semi-perméable qui entoure un compartiment, ce compartiment contenant une première composition osmotique comprenant un agent bénéfique, et une seconde composition osmotique différente de la première, une voie de passage dans la paroi reliant la première composition à l'extérieur du dispositif.
BE0/212326A 1983-05-11 1984-02-02 Dispositif osmotique BE898819A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (1)

Publication Number Publication Date
BE898819A true BE898819A (fr) 1984-05-30

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212326A BE898819A (fr) 1983-05-11 1984-02-02 Dispositif osmotique

Country Status (20)

Country Link
JP (1) JPS6041609A (fr)
AT (1) AT397180B (fr)
AU (1) AU566110B2 (fr)
BE (1) BE898819A (fr)
CA (1) CA1222950A (fr)
CH (1) CH669329A5 (fr)
DE (1) DE3417113A1 (fr)
DK (1) DK163910C (fr)
ES (1) ES8503503A1 (fr)
FR (1) FR2545721B1 (fr)
GB (1) GB2140687B (fr)
IE (1) IE56515B1 (fr)
IL (1) IL71727A (fr)
IT (1) IT1178911B (fr)
MX (1) MX163518B (fr)
NL (1) NL192250C (fr)
NO (1) NO170834C (fr)
NZ (1) NZ206600A (fr)
SE (1) SE455918B (fr)
ZA (1) ZA842422B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
ES2037179T3 (es) * 1987-11-25 1993-06-16 American Cyanamid Company Sistema de liberacion sostenida (controlada) para bloqueadores de canales de calcio de dihidropiridina.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
EP0542926B1 (fr) * 1990-08-07 1995-02-15 Pfizer Inc. Emploi de membranes a polymerisation interfaciale dans des dispositifs de liberation
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
ATE106015T1 (de) * 1990-09-28 1994-06-15 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
ES2158871T3 (es) * 1993-02-23 2001-09-16 Wolfgang Dr Werner Uso de una formulacion de calcio en un medicamento para la aplicacion terapeutica a vacas lecheras que sufren hipocalcemia.
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR101045144B1 (ko) * 2000-10-30 2011-06-30 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
EP1663175B1 (fr) 2003-09-19 2012-03-28 Sun Pharma Advanced Research Company Limited Systeme d'administration de medicament par voie orale
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (fr) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention et traitement de troubles thromboemboliques
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
EP1934208B1 (fr) 2005-10-04 2011-03-23 Bayer Schering Pharma Aktiengesellschaft Nouvelle forme polymorphe de 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
KR20140069381A (ko) * 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 서방출 투여형
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
SG11201406363VA (en) 2012-05-07 2014-11-27 Bayer Pharma AG Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
CA3107169A1 (fr) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Formes galeniques pharmaceutiques a liberation modifiee a administrer par voie orale
EP3826619A1 (fr) 2018-07-24 2021-06-02 Bayer Aktiengesellschaft Formes galéniques pharmaceutiques à libération modifiée à administrer par voie orale

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE376851B (fr) * 1971-01-13 1975-06-16 Alza Corp
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation

Also Published As

Publication number Publication date
AU566110B2 (en) 1987-10-08
DK99784D0 (da) 1984-02-24
GB2140687B (en) 1987-03-18
NL192250C (nl) 1997-04-03
DE3417113A1 (de) 1984-11-15
NO170834B (no) 1992-09-07
NO840248L (no) 1984-11-12
MX163518B (es) 1992-05-25
IL71727A (en) 1989-01-31
AU2251183A (en) 1984-11-15
AT397180B (de) 1994-02-25
DK163910C (da) 1992-09-14
GB8334189D0 (en) 1984-02-01
CA1222950A (fr) 1987-06-16
IL71727A0 (en) 1984-09-30
JPS6041609A (ja) 1985-03-05
IT8467283A0 (it) 1984-03-23
CH669329A5 (fr) 1989-03-15
IT8467283A1 (it) 1985-09-23
IT1178911B (it) 1987-09-16
ZA842422B (en) 1984-11-28
FR2545721B1 (fr) 1987-11-06
DK163910B (da) 1992-04-21
ES532018A0 (es) 1985-03-01
FR2545721A1 (fr) 1984-11-16
SE8402512L (sv) 1984-11-12
NL8401470A (nl) 1984-12-03
GB2140687A (en) 1984-12-05
ATA88084A (de) 1993-07-15
IE840010L (en) 1984-11-11
NL192250B (nl) 1996-12-02
DK99784A (da) 1984-11-12
ES8503503A1 (es) 1985-03-01
NZ206600A (en) 1987-01-23
SE455918B (sv) 1988-08-22
NO170834C (no) 1992-12-16
IE56515B1 (en) 1991-08-28
SE8402512D0 (sv) 1984-05-09
DE3417113C2 (fr) 1989-02-02
JPH0575725B2 (fr) 1993-10-21

Similar Documents

Publication Publication Date Title
BE898819A (fr) Dispositif osmotique
BE898820A (fr) Dispositif osmotique
FR2656928B1 (fr) Dispositif ameliore d'immunotest du type plaquette a plonger, et trousse contenant ce dispositif.
BE902859A (fr) Systeme de revetement de reservoirs
NL186746C (nl) Vloeistofafgeefinrichting en mengkamer.
FR2668242B1 (fr) Bride pour le raccordement des tubulures d'entree et de sortie d'un evaporateur.
DE3887902D1 (de) Fluidischer strömungsmesser.
FR2539300B1 (fr) Dispositif et methode de formation d'un orifice dans la paroi d'une poche thermoplastique pour y inserer par exemple un catheter
MA22119A1 (fr) Granules d'agent de blanchiment contenant un amidoperoxyacide .
MA22679A1 (fr) Dispositif pour delivrer de facon pulsee un liquide d'irrigation et systemes d'irrigation qui incorporent ce dispositif.
IT8722449A0 (it) Dispositivo per l'erogazione pulsata di un liquido di irrigazione ed impianti di irrigazione che incorporano il dispositivo stesso.
NO870810D0 (no) Detersive systemer og lavtskummende vandige opploesninger av overflateaktive midler.
ES513337A0 (es) "aparato de mdida del caudal e un fluido".
IT1233521B (it) Rivelatore di flusso d'ingresso di turbina e sistema di sigillatura.
DK562684A (da) Ikke-forstyrrende fluidblandinger
KR850002818A (ko) 분리조(分離槽)
FR2717099B1 (fr) Agent d'extraction pour l'extraction sélective du strontium dans une solution aqueuse contenant celui-ci.
IT8219695A0 (it) Procedimento per la fabbricazione di tubazioni per l'irrigazione e altri usi.
FR2541745B1 (fr) Dispositif de retenue d'une phase liquide entre une paroi et une piece tournante la traversant
DE3067126D1 (en) A waste trap and a refrigeration unit incorporating such a waste trap
ES516183A0 (es) "un frigorifico que comprende un compartimiento de congelacion y un compartimiento de refrigueracion".
IT8224851A0 (it) Sistema di giunzione di parti separate con possibilita' di unire e distaccare ripetutamente le parti stesse.
FR2605045B1 (fr) Fenetre d'observation a travers une paroi, notamment d'une enceinte radio-active.
IT8222068A0 (it) Sistema per l'ottenimento di funzioni elettroniche complesse mediante la combinazione di funzioni semplici modulari e compatibili.
IT8319480A0 (it) Armatura di parete formata in modocontinuo, procedimento per la realizzazione di tale parete, dispositivo per l'attuazione del procedimento e parete formata comprendente l'armatura.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *ALZA CORP.

Effective date: 20040202